JRJustyna Rajczyk

Justyna Rajczyk

*This is an algorithmically generated author record based on publicly available information.

Justyna Rajczyk has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RARE VASCULAR DISEASES OF THE FEMALE REPRODUCTIVE TRACT: A LITERATURE REVIEW ON THE ETIOLOGY, DIAGNOSIS, AND TREATMENT OF UTERINE ARTERIOVENOUS MALFORMATIONS AND VULVAR ANEURYSMS

    by Justyna Rajczyk, Tomasz Rajczyk, Marcel Bobiński, Aleksandra Sosińska, Zuzanna Wieczorek, Adam Szymczak, Monika Wiczuk-Wiczewska, Justyna Bartol, Wiktoria Skowron, Kamil Kania

    Vascular disorders of the female reproductive tract, including uterine arteriovenous malformations (AVMs) and aneurysms or pseudoaneurysms of the uterine and pudendal arteries, represent extremely rare but potentially life-threatening conditions in gynecology. Due to their low incidence and nonspecific clinical presentation, these entities pose significant diagnostic and therapeutic challenges. Although uncommon, they may result in severe hemorrhage, particularly in the postpartum period or following intrauterine procedures. The aim of this narrative review is to summarize current evidence regarding the etiology, clinical manifestations, diagnostic imaging modalities, and treatment strategies for rare vascular abnormalities of the female reproductive system. A literature search was conducted using PubMed, Scopus, and Web of Science databases, including articles published between 2000 and 2025. Available data indicate that color Doppler ultrasonography is the primary diagnostic tool, while magnetic resonance imaging and angiography play a crucial role in confirmation and treatment planning. Selective endovascular embolization has emerged as the gold-standard therapy, providing high efficacy in hemorrhage control while preserving uterine integrity and reproductive potential in most patients. Despite favorable outcomes, standardized diagnostic and therapeutic algorithms are lacking. Further multicenter studies and case registries are required to optimize management strategies for these rare but clinically significant conditions.

  • Open Access

    SENOLYTICS – A DISCOVERY THAT COULD TRANSFORM THE COURSE OF AGING AND CHRONIC DISEASES

    by Kamil Kania, Marcel Bobiński, Zuzanna Wieczorek, Wiktoria Skowron, Justyna Bartol, Aleksandra Sosińska, Justyna Rajczyk, Monika Wiczuk–Wiczewska, Adam Szymczak, Tomasz Lepich

    Senescent cells play a pivotal role in the progression of age-related diseases by promoting chronic inflammation and disrupting tissue function through the secretion of senescence-associated secretory phenotype (SASP) factors. Senolytics, a novel class of therapeutic agents, enable the selective elimination of these cells or the attenuation of their deleterious effects, offering a potential avenue to enhance healthspan. Preclinical studies and early clinical trials indicate that senolytics can improve cardiovascular function, metabolism, and physical performance, while demonstrating an acceptable safety profile. This review presents the mechanisms of action of senolytics, the current state of research, and their potential applications in metabolic, neurodegenerative, and cardiovascular diseases.

  • Open Access

    DEVELOPMENTAL CARDIAC ANOMALIES IN CHILDREN WITH EDWARDS SYNDROME: A COMPREHENSIVE REVIEW

    by Dominik Szklarkowski, Klaudia Romejko, Wiktor Kubik, Michał Górski, Jan Nowak, Barbara Kujawa, Bartosz Zwoliński, Kacper Sukiennicki, Wirginia Bertman, Natalia Kołdej, et al.

    Introduction and objective: Edwards Syndrome, also known as Trisomy 18, is the second most common autosomal trisomy following Down Syndrome. This chromosomal disorder is characterized by the presence of a third copy of chromosome 18, in contrast to the usual two. The condition is associated with a wide spectrum of severe congenital anomalies, significant developmental delays, and a high rate of fetal loss and infant mortality. Therefore, a comprehensive synthesis of these associated developmental anomalies is crucial for accurate prenatal counseling, clinical guidance, and postnatal management. The primary objective of this comprehensive review is to systematically identify, collate, and synthesize the existing literature regarding the range and prevalence of congenital heart defects in children diagnosed with Edwards Syndrome. Recognizing that cardiac anomalies are a cardinal feature and a leading cause of mortality in this condition, this review aims to provide a detailed, evidence-based overview of these specific manifestations. Ultimately, this focused analysis seeks to enhance clinical understanding of the cardiovascular complications in Edwards Syndrome and inform targeted management strategies. Brief description of the state of knowledge: Edwards Syndrome (Trisomy 18) is characterized by a high burden of congenital anomalies, with cardiac defects affecting the vast majority of patients and serving as a primary determinant of survival. Historically regarded as a uniformly lethal condition requiring only palliative care, the clinical perspective is evolving. Recent data indicate that cardiac interventions may offer survival benefits, challenging traditional non-interventional paradigms and necessitating an updated understanding of the cardiovascular phenotype. Methods: A systematic literature review was performed by searching major biomedical databases (PubMed, Google Scholar, Elicit) using a combination of keywords and MeSH terms, including "Edwards Syndrome" and "congenital abnormalities." Inclusion criteria prioritized peer-reviewed articles such as case series, observational studies, and systematic reviews. Data extraction focused on the types, frequency, and systemic impact of anomalies, as well as postnatal developmental outcomes. The collected data were then synthesized to create a comprehensive syndrome profile. Conclusions: The clinical paradigm for Edwards Syndrome is shifting from a uniform designation of lethality toward a personalized, multidisciplinary model. Accurate prenatal diagnosis via fetal echocardiography is essential for early risk stratification. Contemporary management requires a balanced approach integrating palliative care with the option of active cardiac intervention. Consequently, parental counseling must emphasize shared decision-making, providing families with evidence-based data on potential surgical outcomes to optimize the quality of life for the affected child.

  • Open Access

    NAD METABOLISM IN THE PATHOPHYSIOLOGY AND THERAPY OF PARKINSON'S DISEASE

    by Illia Koval, Klaudia Romejko, Barbara Kujawa, Jagoda Saniuk, Sandra Sienkiewicz, Justyna Rajczyk, Weronika Kielińska, Joanna Osmólska, Michał Dorota, Kacper Wojtala

    This paper explores the rapidly increasing incidence of Parkinson's disease (PD) and the limitations of current dopamine-based therapies, which only address symptoms rather than underlying causes. This has spurred research into novel treatment approaches rooted in the disease's pathophysiology. A key pathological hallmark of PD is mitochondrial dysfunction, particularly affecting complex I, a critical component of cellular energy metabolism. This discovery has directed investigations toward individual elements of mitochondrial pathways, including the NAD+/NADH redox balance. Studies indicate reduced NAD+ levels in the brains of individuals with PD, prompting research into the therapeutic effects of NAD+ supplementation. This review summarizes recent scientific findings on how augmenting NAD+ and its derivatives may influence Parkinson's disease. It discusses the impact of NAD+ precursor supplementation on mitochondrial function and NAD+ levels in neurons carrying the GBA mutation. The paper also covers defects in PINK1 expression, their link to PD development, and the potential role of Nicotinamide (vitamin B3) in this context. Additionally, it assesses the safety of oral NAD+ precursor supplementation and its effects on brain NAD+ levels and metabolism in PD patients. A deeper understanding of PD pathophysiology and continued research into raising NAD+ levels are vital for developing novel therapeutic strategies. Modulating NAD+ holds significant promise as a supportive or disease-modifying therapy for this neurodegenerative condition.

  • Open Access

    DIABETES IN POLAND: EPIDEMIOLOGY, MORTALITY AND DIAGNOSTICS

    by Illia Koval, Klaudia Romejko, Barbara Kujawa, Sandra Sienkiewicz, Jagoda Saniuk, Justyna Rajczyk, Aleksandra Oparcik, Kacper Wojtala, Weronika Kielińska, Małgorzata Golik, et al.

    This paper presents current knowledge on diabetes mellitus (ICD-10 E10-E14) and its clinical impact. Diabetes is a growing global problem, with over 3 million adults affected in Poland alone. The disease develops as type 1, caused by autoimmune destruction of pancreatic β-cells, or as type 2, driven mainly by insulin resistance and obesity. Both forms lead to impaired glucose uptake and abnormal fat and protein metabolism. Common symptoms include thirst, polyuria, fatigue, weight loss, and recurrent infections, though type 2 diabetes often remains silent for years. Persistent hyperglycemia promotes toxic metabolite accumulation, microangiopathy, neuropathy, and multiorgan complications. Cardiovascular manifestations, such as diabetic cardiomyopathy and arrhythmias, significantly increase morbidity and mortality. Early detection, lifestyle modification, and improved diagnostic strategies remain essential to reduce the burden of disease.

  • Open Access

    PROLACTIN AS A HORMONE RESPONSIVE TO PHYSICAL EXERCISE

    by Wiktoria Skowron, Mateusz Kalita, Marcel Bobiński, Justyna Bartol, Klaudia Romejko, Justyna Rajczyk, Monika Wiczuk-Wiczewska, Zuzanna Wieczorek, Adam Szymczak, Aleksandra Kozińska

    Background. Physical exercise is a major physiological stressor that affects the human endocrine system. Among the hormones responsive to physical exertion is prolactin (PRL), known primarily for its role in lactation but also involved in stress regulation, immune function, metabolism, and reproduction. Aim. This article aims to review current knowledge on the effects of intense physical activity on prolactin levels and the potential consequences for hormonal balance in athletes. Material and methods. A systematic literature review was conducted using PubMed and Scopus databases. Inclusion criteria were English-language articles with full-text access, including original and review papers analyzing prolactin changes in response to exercise in humans. A total of 183 publications were screened, and those not meeting the methodological or thematic criteria were excluded. Results. Intense physical exercise, particularly above the anaerobic threshold (e.g., HIIT), causes a sharp and transient increase in prolactin levels, with the response magnitude influenced by exercise intensity, duration, and environmental factors. Regular training may modulate both baseline prolactin levels and acute hormonal responses. Differences based on sex, training status, and menstrual cycle phase were also observed. Prolactin’s rise post-exercise may contribute to metabolic adaptation, immune modulation, and recovery processes. However, chronically elevated PRL levels—common in overtrained individuals—can negatively affect reproductive and metabolic health. Conclusions. Prolactin plays a broader physiological role than previously appreciated. Its exercise-induced elevation reflects the integration of neuroendocrine and immune responses to physical stress. Understanding this hormonal response is essential in optimizing training protocols, supporting recovery, and preventing endocrine dysfunction in athletes.